Gamma Medica, Exxim Computing Corp sign development and sales agreement

Gamma Medica Inc. will exclusively license an enhancement package from Exxim Computing Corp. for use on its X-SPECT pre-clinical imaging system.

Gamma Medica has been delivering the standard version of Exxim's Cobra software for reconstruction of x-ray CT images produced by X-SPECT since the summer of 2003, and now will be delivering an enhanced version under this exclusive arrangement.

The new enhancements include DICOM support and beam hardening correction, which improves the reconstructed CT image quality by correcting anomalous dark shadows between and around bone structures that occur as a by-product in CT imaging.

X-SPECT, Gamma Medica's second-generation MicroSPECT system, is a specialty imaging system used by medical researchers and drug companies that use in-vivo imaging techniques and molecular markers to speed up studies of disease progression and therapy. The X-SPECT system combines the functional nuclear medicine technique, SPECT, with anatomical imaging provided by x-ray CT.

Together with its U.S. marketing partner, Siemens Medical Solutions USA Inc., Gamma Medica sells its MicroSPECT products to bio-pharmaceutical companies, research hospitals and universities.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.